The blood group typing market will register a CAGR of almost 10% by 2023.
In recent years, the increasing prevalence of chronic diseases such as diabetes and cancer among individuals is leading to a rising demand for early diagnosis for better patient care.
Blood group testing is necessary for cancer patients, as the disease may require blood transfusion for treatment. Blood products such as platelets used for treating cancer patients have a shorter shelf-life, which increases the demand for blood products. The increase in the prevalence of chronic diseases, coupled with the demand for early diagnosis through blood group typing, has significantly led to the growth of the market.
Rise in donation rates owning to increase in awareness
There has been an increase in the blood donation rate due to the rising importance and awareness of blood donation. Therefore, the demand for blood group typing products such as instruments, consumables, and reagents among end-users such as hospitals, clinics, and blood banks is increasing.
Risks associated with blood transfusion
Blood transfusions involve the risk of complications during or post transfusion. Some of the risks and complications of blood transfusion include acute immune hemolytic reaction wherein the immune system attacks the transfused red blood cells because the donor blood type is not a good match. Thus, the complications and risks arising as a result of blood transfusion are restricting the growth of the global blood group typing market.
The global blood group typing market is moderately concentrated and as the market is in its growth phase, the competition among companies is intense. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.
Agena BioscienceBio-Rad LaboratoriesDanaherMerck KGaAOrtho Clinical Diagnostics
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
Market ecosystemMarket characteristicsMarket segmentation analysis
PART 04: MARKET SIZING
Market definitionMarket sizing 2018Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
Bargaining power of buyersBargaining power of suppliersThreat of new entrantsThreat of substitutesThreat of rivalryMarket condition
PART 06: MARKET SEGMENTATION BY PRODUCT
Comparison by productConsumables - Market size and forecast 2018-2023Instruments - Market size and forecast 2018-2023Software - Market size and forecast 2018-2023Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
Geographic comparisonNorth America - Market size and forecast 2018-2023Europe - Market size and forecast 2018-2023Asia - Market size and forecast 2018-2023ROW - Market size and forecast 2018-2023Key leading countriesMarket opportunity
PART 09: DRIVERS AND CHALLENGES
PART 10: MARKET TRENDS
Technological advances focusing on advanced techniques and automated systemsIncreasing government support pertaining to blood safetyGrowing demand for blood transfusions and blood group typing
PART 11: VENDOR LANDSCAPE
PART 12: VENDOR ANALYSIS
Vendors coveredVendor classificationMarket positioning of vendorsAgena BioscienceBio-Rad LaboratoriesDanaherMerck KGaAOrtho Clinical Diagnostics
For more information about this report visit https://www.researchandmarkets.com/research/4l43bd/the—worldwide?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20190207005611/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Blood Banking
INDUSTRY KEYWORD: HEALTH OTHER HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 02/07/2019 11:15 AM/DISC: 02/07/2019 11:15 AM